Multidrug resistant tuberculosis

Por GEERLIGS, W, VAN ALTENA, R, VAN DER WERF, T S
Publicado em 2001

Relation between beta-lactamase producing bacteria and patient characteristics in chronic obstructive pulmonary disease (COPD).

Por Sportel, J. H., Koëter, G. H., van Altena, R., Löwenberg, A., Boersma, W. G.
Publicado em 1995

Clinical and bacteriological efficacy and tolerability of FCE 22891 in patients with exacerbations of chronic obstructive pulmonary disease.

Por Boersma, W G, Puister, S M, van Altena, R, de Vries-Hospers, H G, Molinari, M, Koëter, G H
Publicado em 1994

Reliability and validity of the chronic respiratory questionnaire (CRQ).

Por Wijkstra, P. J., TenVergert, E. M., Van Altena, R., Otten, V., Postma, D. S., Kraan, J., Koëter, G. H.
Publicado em 1994

Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease.

Por Wijkstra, P. J., Ten Vergert, E. M., van Altena, R., Otten, V., Kraan, J., Postma, D. S., Koëter, G. H.
Publicado em 1995

Plasma and Cerebrospinal Fluid Pharmacokinetics of Moxifloxacin in a Patient with Tuberculous Meningitis

Por Alffenaar, J. W. C., de Vries, P. M., Luijckx, G. J., van Soolingen, D., van der Werf, T. S., van Altena, R.
Publicado em 2008

Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease.

Por Wijkstra, P. J., TenVergert, E. M., van der Mark, T. W., Postma, D. S., Van Altena, R., Kraan, J., Koëter, G. H.
Publicado em 1994

Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer

Por Altena, R, de Haas, E C, Nuver, J, Brouwer, C A J, van den Berg, M P, Smit, A J, Postma, A, Sleijfer, D Th, Gietema, J A
Publicado em 2009

Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis

Por van Altena, R., Dijkstra, J. A., van der Meer, M. E., Borjas Howard, J. F., Kosterink, J. G. W., van Soolingen, D., van der Werf, T. S., Alffenaar, J. W. C.
Publicado no Antimicrob Agents Chemother (2017)

Clinical Validation of the Analysis of Linezolid and Clarithromycin in Oral Fluid of Patients with Multidrug-Resistant Tuberculosis

Por Bolhuis, M. S., van Altena, R., van Hateren, K., de Lange, W. C. M., Greijdanus, B., Uges, D. R. A., Kosterink, J. G. W., van der Werf, T. S., Alffenaar, J. W. C.
Publicado em 2013

Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Linezolid in Patients with Multidrug-Resistant Tuberculosis

Por Vu, D. H., Bolhuis, M. S., Koster, R. A., Greijdanus, B., de Lange, W. C. M., van Altena, R., Brouwers, J. R. B. J., Uges, D. R. A., Alffenaar, J. W. C.
Publicado em 2012

Pharmacokinetics of 2,000 Milligram Ertapenem in Tuberculosis Patients

Por Zuur, M. A., Ghimire, S., Bolhuis, M. S., Wessels, A. M. A., van Altena, R., de Lange, W. C. M., Kosterink, J. G. W., Touw, D. J., van der Werf, T. S., Akkerman, O. W., Alffenaar, J. W. C.
Publicado no Antimicrob Agents Chemother (2018)

Pharmacokinetic Modeling and Limited Sampling Strategies Based on Healthy Volunteers for Monitoring of Ertapenem in Patients with Multidrug-Resistant Tuberculosis

Por van Rijn, S. P., Zuur, M. A., van Altena, R., Akkerman, O. W., Proost, J. H., de Lange, W. C. M., Kerstjens, H. A. M., Touw, D. J., van der Werf, T. S., Kosterink, J. G. W., Alffenaar, J. W. C.
Publicado no Antimicrob Agents Chemother (2017)

Isoniazid resistant TB and non-compliance

Por van Altena, R, van Soolingen, D, van der Werf, T S, Ruddy, M, Yates, M, Drobniewski, F, Davies, A, Drabu, Y, Patel, B, Yates, S, Lozewicz, S, Sen, S, Bahl, M, James, E, Lipman, M, Balasegaram, S, Duckworth, G, Watson, J, Piper, M, Maguire, H
Publicado em 2004

Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors

Por Boer, H., Proost, J. H., Nuver, J., Bunskoek, S., Gietema, J. Q., Geubels, B. M., Altena, R., Zwart, N., Oosting, S. F., Vonk, J. M., Lefrandt, J. D., Uges, D. R. A., Meijer, C., de Vries, E. G. E., Gietema, J. A.
Publicado no Ann Oncol (2015)

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

Por Beyer, J., Albers, P., Altena, R., Aparicio, J., Bokemeyer, C., Busch, J., Cathomas, R., Cavallin-Stahl, E., Clarke, N. W., Claßen, J., Cohn-Cedermark, G., Dahl, A. A., Daugaard, G., De Giorgi, U., De Santis, M., De Wit, M., De Wit, R., Dieckmann, K. P., Fenner, M., Fizazi, K., Flechon, A., Fossa, S. D., Germá Lluch, J. R., Gietema, J. A., Gillessen, S., Giwercman, A., Hartmann, J. T., Heidenreich, A., Hentrich, M., Honecker, F., Horwich, A., Huddart, R. A., Kliesch, S., Kollmannsberger, C., Krege, S., Laguna, M. P., Looijenga, L. H. J., Lorch, A., Lotz, J. P., Mayer, F., Necchi, A., Nicolai, N., Nuver, J., Oechsle, K., Oldenburg, J., Oosterhuis, J. W., Powles, T., Rajpert-De Meyts, E., Rick, O., Rosti, G., Salvioni, R., Schrader, M., Schweyer, S., Sedlmayer, F., Sohaib, A., Souchon, R., Tandstad, T., Winter, C., Wittekind, C.
Publicado em 2013

Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Ind...

Por Bastos, Mayara L., Hussain, Hamidah, Weyer, Karin, Garcia-Garcia, Lourdes, Leimane, Vaira, Leung, Chi Chiu, Narita, Masahiro, Penã, Jose M., Ponce-de-Leon, Alfredo, Seung, Kwonjune J., Shean, Karen, Sifuentes-Osornio, José, Van der Walt, Martie, Van der Werf, Tjip S., Yew, Wing Wai, Menzies, Dick, Ahuja, S., Ashkin, D., Avendaño, M., Banerjee, R., Bauer, M., Becerra, M., Benedetti, A., Burgos, M., Centis, R., Chan, E.D., Chiang, C.Y., Cobelens, F., Cox, H., D'Ambrosio, L., de Lange, W.C.M., DeRiemer, K., Enarson, D., Falzon, D., Flanagan, K., Flood, J., Gandhi, N., Garcia-Garcia, L., Granich, R.M., Hollm-Delgado, M.G., Holtz, T.H., Hopewell, P., Iseman, M., Jarlsberg, L.G., Keshavjee, S., Kim, H.R., Koh, W.J., Lancaster, J., Lange, C., Leimane, V., Leung, C.C., Li, J., Menzies, D., Migliori, G.B., Mitnick, C.M., Narita, M., Nathanson, E., Odendaal, R., O'Riordan, P., Pai, M., Palmero, D., Park, S.K., Pasvol, G., Pena, J., Pérez-Guzmán, C., Ponce-de-Leon, A., Quelapio, M.I.D., Quy, H.T., Riekstina, V., Robert, J., Royce, S., Salim, M., Schaaf, H.S., Seung, K.J., Shah, L., Shean, K., Shim, T.S., Shin, S.S., Shiraishi, Y., Sifuentes-Osornio, J., Sotgiu, G., Strand, M.J., Sung, S.W., Tabarsi, P., Tupasi, T.E., Vargas, M.H., van Altena, R., van der Walt, M., van der Werf, T.S., Viiklepp, P., Westenhouse, J., Yew, W.W., Yim, J.J.
Publicado no Clin Infect Dis (2014)